SUMMARY We describe a laboratory test which is useful in determining whether deafness is due to intrauterine rubella. The study group consisted of 8 deaf patients with proved intrauterine rubella, 12 patients with familial deafness, and 17 controls. Blood was taken at time 0 from all of them. All the deaf children and 5 controls were immunised and further blood samples taken at 2 and 6 weeks. Each blood sample was analysed for the lymphocyte response to rubella in vitro and for the presence of rubella haemagglutination inhibition. All the rubella-affected patients had antibody titres to rubella at time 0 and there was no notable change after immunisation. None of these patients had a significant lymphocyte response to rubella antigen at any time. Eight of the familial deaf patients and 13 of the controls had positive antibody titres. With the exception of one patient whose results were equivocal, all the familial deaf patients and controls in whom antibodies were detected had lymphocyte responses to rubella. In those with undetectable antibodies the lymphocytes failed to respond in vitro to rubella antigen.
The diagnosis of intrauterine rubella is easy to confirm in an infant who has some of the classic features of the disease.' In other rubella-affected children the clinical diagnosis may be difficult to make, particularly in those of mothers infected late in pregnancy whose only clinical feature may be nerve deafness which may not be diagnosed in infancy when viral culture could offer confirmation.2 This difficulty in diagnosis creates a problem in genetic counselling of a family with one nerve deaf child. If the aetiology of the deafness is intrauterine rubella infection, it is unlikely that subsequent children will be affected.
The purpose of this study was to test the hypothesis that the immunological response to rubella virus antigen will be different in patients whose deafness is due to intrauterine rubella than in patients with nerve deafness due to other causes. In so doing we hoped to develop a useful diagnostic test using readily available reagents.
Materials and methods
Patients and controls. Twenty patients with nerve deafness were investigated. In 8 of these there was irrefutable evidence of intrauterine rubella infection. Such evidence consisted of other major manifestations of rubella embryopathy-such as cataract and congenital heart lesions, or the isolation of rubella virus at birth, or an increase in rubella antibody titre in pregnancy after a viral infection suggestive of rubella. The mothers of 3 patients gave a history of a rash consistent with or proved to be rubella during pregnancy. These rashes occurred at 6, 8, and 12 weeks of pregnancy.
The 12 other nerve-deaf patients, consisting of five sets of siblings, all had a strong family history of nerve deafness. The ages of the intrauterine rubella patients ranged from 7 to 24 years with a median of 14. The ages of the other deaf patients ranged from 3 to 28 years with a median of 13 group.bmj.com on July 7, 2017 -Published by http://adc.bmj.com/ Downloaded from
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Our findings are in agreement with those of Buimovici-Klein et al.4 who demonstrated impaired lymphocyte responsiveness to rubella antigen in vitro in children with deafness due to intrauterine rubella. Some patients with intrauterine rubella have been reported as having evidence of cell mediated immunity to rubella in vitro.8 However the assay used was different from the one we used.
The lymphocyte response in vitro 2 and 6 weeks after immunisation did not always rise to significant levels in the antibody negative non-rubella deaf patients and controls. Two of 6 of this combined group had significant lymphocyte responses by 6 weeks.
One interesting feature is that in non-rubella patients and controls with antibody, rubella immunisation produced a decline in the lymphocyte responsiveness 2 weeks after immunisation.
Only one child with congenital rubella had a positive lymphocyte response to rubella antigen in any of the three samples.
With regard to the antibody-negative controls, it may be that the final 6-week sample was taken too early for maximal response as the 2 controls who had a low positive response (3.6, 3-9) by 6 weeks, had an increased response (4.5, 4.5 
